5077 |
Directional Atherectomy for Complex Femoropopliteal Artery: Where Are We, How to Do |
Ravish Sachar |
Apr. 27. 19 |
5076 |
Heavy Calcific SFA Lesion: How to Cross with Wire and Balloon |
Su Hong Kim |
Apr. 27. 19 |
5075 |
Sirolimus DCBs for Femoral-Popliteal Disease: Emerging Role and Future Perspectives |
Robert Bersin |
Apr. 27. 19 |
5074 |
Paclitaxel DCBs for Femoral-Popliteal Disease: Pitfall and Current Status |
Sang Woo Park |
Apr. 27. 19 |
5073 |
Heavy Calcific Femoral-Popliteal Lesions: Non-atherectomy Strategy and Bailout Stenting Is Still Better. |
Young-Guk Ko |
Apr. 27. 19 |
5072 |
Heavy Calcific Femoral-Popliteal Lesion: Atherectomy and DCB Is Standard. |
Ravish Sachar |
Apr. 27. 19 |
5071 |
Meta-analysis of Randomized CTO Trials Comparing PCI Versus OMT |
Pil Hyung Lee |
Apr. 27. 19 |
5070 |
REVASC Trial: Cool Down or Heat up CTO Intervention? |
Kambis Mashayekhi |
Apr. 27. 19 |
5069 |
Message and Lessons from Updated EUROCTO Trial |
Gerald Werner |
Apr. 27. 19 |
5068 |
Septal Channel: How to Pass |
Yasumi Igarashi |
Apr. 27. 19 |